Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Borte

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Allergy and Clinical Immunology|June 12, 2017
Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4<sup>+</sup> and CD8<sup>+</sup> T cells-clinical applications in primary immunodeficiency diagnosticsMichael Bitar, Andreas Boldt, Stefanie Binder, et al.
BMC Public Health|April 30, 2022
Maternal stress, child behavior and the promotive role of older siblingsFederica Amici, Stefan Röder, Wieland Kiess, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 19, 2006
Margarine and butter consumption, eczema and allergic sensitization in children. The LISA birth cohort studyStefanie Sausenthaler, Iris Kompauer, Michael Borte, et al.
Drug Testing and Analysis|December 30, 2014
Monitoring of drug intake during pregnancy by questionnaires and LC-MS/MS drug urine screening: evaluation of both monitoring methodsHenrike Hoeke, Stefan Roeder, Thilo Bertsche, et al.
Cancers|September 28, 2023
Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup AnalysisMaria Dimou, Matthaios Speletas, Cinzia Milito, et al.
The Science of the Total Environment|February 15, 2011
Respiratory effects of indoor particles in young children are size dependentUlrich Franck, Olf Herbarth, Stefan Röder, et al.
Advances in Therapy|September 26, 2023
Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency DiseasesMaria Fasshauer, Michael Borte, Michaela Bitzenhofer, et al.
Vox Sanguinis|August 9, 2022
Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency diseaseGergely Kriván, Michael Borte, James B Harris, et al.
Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2014
Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficienciesAndreas Boldt, Stephan Borte, Stephan Fricke, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Allergy and Clinical Immunology|June 12, 2017
Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4<sup>+</sup> and CD8<sup>+</sup> T cells-clinical applications in primary immunodeficiency diagnosticsMichael Bitar, Andreas Boldt, Stefanie Binder, et al.
BMC Public Health|April 30, 2022
Maternal stress, child behavior and the promotive role of older siblingsFederica Amici, Stefan Röder, Wieland Kiess, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 19, 2006
Margarine and butter consumption, eczema and allergic sensitization in children. The LISA birth cohort studyStefanie Sausenthaler, Iris Kompauer, Michael Borte, et al.
Drug Testing and Analysis|December 30, 2014
Monitoring of drug intake during pregnancy by questionnaires and LC-MS/MS drug urine screening: evaluation of both monitoring methodsHenrike Hoeke, Stefan Roeder, Thilo Bertsche, et al.
Cancers|September 28, 2023
Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup AnalysisMaria Dimou, Matthaios Speletas, Cinzia Milito, et al.
The Science of the Total Environment|February 15, 2011
Respiratory effects of indoor particles in young children are size dependentUlrich Franck, Olf Herbarth, Stefan Röder, et al.
Advances in Therapy|September 26, 2023
Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency DiseasesMaria Fasshauer, Michael Borte, Michaela Bitzenhofer, et al.
Vox Sanguinis|August 9, 2022
Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency diseaseGergely Kriván, Michael Borte, James B Harris, et al.
Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2014
Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficienciesAndreas Boldt, Stephan Borte, Stephan Fricke, et al.
Pageof 13